DONNA JAWORSKI: Open Payments
NPI 1982764312 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$701 in 35 payments from 16 companies in 2025. Trend: 2023 $649 · 2024 $795 · 2025 $701
Food & beverage: $701
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $107 |
| Insulet Corporation | 4 | $100 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Novo Nordisk Inc | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
| Abbott Laboratories | 2 | $34 |
| Ionis Pharmaceuticals, Inc. | 1 | $32 |
| Mannkind Corporation | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
Products named: JARDIANCE, Omnipod, TRELEGY ELLIPTA, AIRSUPRA, UBRELVY, FREESTYLE LIBRE 3, AFREZZA, Wegovy.
Industry payments across NY — which companies pay providers there.
